Low-dose interleukin-2 therapy is not associated with cutaneous toxicity after autologous transplantation

Bone Marrow Transplant. 1996 Aug;18(2):481-2.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Bone Marrow Transplantation*
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Interleukin-2 / adverse effects*
  • Male
  • Middle Aged
  • Skin / drug effects*
  • Transplantation, Autologous

Substances

  • Interleukin-2